Inactivation of the Mouse Huntington's Disease Gene Homolog Hdh
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Huntington's disease (HD) is a dominant neurodegenerative disorder caused by expansion of a CAG repeat in the gene encoding huntingtin, a protein of unknown function. To distinguish between "loss of function" and "gain of function" models of HD, the murine HD homolog Hdh was inactivated by gene targeting. Mice heterozygous for Hdh inactivation were phenotypically normal, whereas homozygosity resulted in embryonic death. Homozygotes displayed abnormal gastrulation at embryonic day 7.5 and were resorbing by day 8.5. Thus, huntingtin is critical early in embryonic development, before the emergence of the nervous system. That Hdh inactivation does not mimic adult HD neuropathology suggests that the human disease involves a gain of function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar to α-syn in PD and Tau in AD, polyQ-HTT aggregates exert toxic gain-of-function effects, forming β-sheet-rich structures that disrupt essential cellular pathways and cause neurotoxicity [169,170].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [169]
In the citing paper
“Similar to α-syn in PD and Tau in AD, polyQ-HTT aggregates exert toxic gain-of-function effects, forming β-sheet-rich structures that disrupt essential cellular pathways and cause neurotoxicity [169,170].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [169]
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Self-citationVerkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.
Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., & Roder, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8424 · Cited by 2,329
Neuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227
Self-citationAbsence of expression of the FMR-1 gene in fragile X syndrome
Pieretti, M., Zhang, F., Fu, Y.-H., Warren, S. T., Oostra, B. A., Caskey, C. T., & Nelson, D. L. (1991) · Cell · doi:10.1016/0092-8674(91)90125-i · Cited by 1,476
Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene
Tybulewicz, V. L. J., Crawford, C. E., Jackson, P. K., Bronson, R. T., & Mulligan, R. C. (1991) · Cell · doi:10.1016/0092-8674(91)90011-m · Cited by 1,281
Fmr1 knockout mice: A model to study fragile X mental retardation
THEDUTCHBELGIANFRAGILEXCONSOR (1994) · Cell · doi:10.1016/0092-8674(94)90569-x · Cited by 1,035
Nasir, J., Floresco, S. B., O'Kusky, J. R., Diewert, V. M., Richman, J. M., Zeisler, J., Borowski, A., Marth, J. D., Phillips, A. G., & Hayden, M. R. (1995) · Cell · doi:10.1016/0092-8674(95)90542-1 · Cited by 872
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
DiFiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young, C., Martin, E., Vonsattel, J.-P., Carraway, R., Reeves, S. A., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90346-1 · Cited by 749
Self-citationDNA methylation represses FMR-1 transcription in fragile X syndrome
Sutcliffe, J. S., Nelson, D. L., Zhang, F., Pieretti, M., Caskey, C. T., Saxe, D., & Warren, S. T. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.6.397 · Cited by 680
Research works printed but not linked: 3
- CELL 78: 23 (1994).
- Nagy, A., Gene Targeting: A Practical Approach: 147 (1993).
- Wurst, W., Gene Targeting: A Practical Approach: 31 (1993).
Cited by
Items 601–700 of 885
Therapeutics in Huntington’s Disease
Rosas, H. D., & Koroshetz, W. J. (2002) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-06274-6_17 · Cited by 2
Cognitive and synaptic dysfunction in a mouse model of Huntington's disease
Mitchell, R. C. (2012) · Discovery Research Portal (University of Dundee) · Cited by 2
Modeling Neurodegenerative Diseases in the Fruit Fly
Jackson, G. R. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-006-3_16 · Cited by 2
Probing the interaction between huntingtin and NMDA receptors
Icton, C. D. (2009) · cIRcle (University of British Columbia) · doi:10.14288/1.0090000 · Cited by 2
Functional and Localization Studies of Human Kynurenine 3-Monooxygenase
Swaih, A. M. (2016) · Figshare · Cited by 2
Oxidative stress in Huntington's disease knock-in striatal cells
Ribeiro, M. J. D. C. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 2
Szlachcic, W. J., Wiatr, K., Trzeciak, M., Figlerowicz, M., & Figiel, M. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00312 · Cited by 2
Computational and chemical approaches to drug repurposing
Li, X. (2023) · Open Archive (Karolinska Institutet) · Cited by 2
Pérot, J. (2021) · theses.fr (ABES) · doi:10.70675/30d838b2zfd7dz49bfzbb74zae324e91e7ac · Cited by 2
Etiology, Pathology, and Pathogenesis
Weydt, P., Landwehrmeyer, G. B., & Ludolph, A. C. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00024-6 · Cited by 1
Mouse models to interrogate the developmental pathogenesis of Huntington's disease
Altun, Y., Yan, S., Zheng, K., Molero, A. E., & Mehler, M. F. (2026) · Journal of Huntington s Disease · doi:10.1177/18796397251412135 · Cited by 1
Wild-type huntingtin in neurodevelopment
Chan, L., & Leavitt, B. R. (2026) · Journal of Huntington s Disease · doi:10.1177/18796397251410442 · Cited by 1
Use of Genetically Engineered Mice to Study the Biology of Huntingtin
Dietrich, P., & Dragatsis, I. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405195-9.00032-9 · Cited by 1
The role of polyglutamine aggregate cytotoxicity in Huntington’s Disease
Yang, W. (2003) · Cited by 1
Huntington's Disease and Polyglutamine Expansion Neurodegenerative Diseases
Crichton, R. R., & Ward, R. J. (2005) · Wiley eBooks · doi:10.1002/0470022574.ch5 · Cited by 1
Molecular biology of the InsP3Rs: focus on brain function in health and disease
Hisatsune, C., & Mikoshiba, K. (2012) · Wiley Interdisciplinary Reviews Membrane Transport and Signalling · doi:10.1002/wmts.48 · Cited by 1
Allele-Specific Conditional Destabilization of Glutamine Repeat mRNAs
Crouse, A. B., & Detloff, P. J. (2005) · Gene Expression · doi:10.3727/000000005783992089 · Cited by 1
Neurodegeneration models in Drosophila
Roy, B., & Jackson, G. R. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9780511920585.012 · Cited by 1
MECHANISMS OF POLYGLUTAMINE EXPANDED HUNTINGTIN INDUCED TOXICITY
Jiang, H. (2003) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Mitochondrial Dynamics and Huntington’s Disease: A Dance of Fate
Wang, H., Karbowski, M., & Monteiro, M. J. (2011) · Springer eBooks · doi:10.1007/978-94-007-1291-1_9 · Cited by 1
Neurodegenerative Diseases: Insights from Drosophila and Mouse Models
Botas, J. (2003) · Research and perspectives in neurosciences · doi:10.1007/978-3-642-55543-5_6 · Cited by 1
Regulation of Transglutaminase by 5-HT2A Receptor Signaling and Calmodulin
Dai, Y. (2009) · Loyola eCommons (Loyola University of Chicago) · Cited by 1
Hogel, M. (2012) · Library and Archives Canada (Government of Canada) · Cited by 1
NR1 Receptor Gene Variation is a Modifier of Age at Onset in Turkish Huntington’s Disease Patients
Acar-Hazer, A., & Tunalı, N. E. (2017) · InTech eBooks · doi:10.5772/67766 · Cited by 1
Naha, N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820595-2.00014-x · Cited by 1
Neurotoxicity in Huntington Disease
Loy, C. T., & Hannan, A. J. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_140 · Cited by 1
Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00013-5 · Cited by 1
Preclinical Experimental Therapeutics
Bates, G. P., & Landles, C. (2014) · Oxford University Press eBooks · doi:10.1093/med/9780199929146.003.0016 · Cited by 1
Neurotoxicity in Huntington Disease
Loy, C. T., & Hannan, A. J. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_140 · Cited by 1
Systems biology study of Huntington's disease
Dionisio, L. E., Langfelder, P., Aaronson, J. S., Rosinski, J., & Yang, X. W. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95672-7.00006-6 · Cited by 1
Chapter 3 The Genetic Basis and Molecular Pathogenesis of Huntington's Disease
Kowall, N. W., Kuemmerle, S., & Ferrante, R. J. (1999) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(08)60023-1 · Cited by 1
Apoptosis gene expression profiling in lens development
Geatrell, J. C. (2007) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 1
Characterization of a Drosophila model of Huntington's disease
Lee, W.-C. M. (2006) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 1
Therapeutic Potential of Small Interfering RNA for Brain Diseases
Lovett‐Racke, A. E. (2009) · Springer eBooks · doi:10.1007/978-3-642-00475-9_13 · Cited by 1
Characterising the structural brain changes in Huntington’s disease using translational neuroimaging
Steventon, J. J. (2014) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 1
Analysis of Huntingtin-interacting protein 1 in Drosophila melanogaster
Moores, J. N. (2007) · Memorial University Research Repository (Memorial University) · Cited by 1
Genetics of Movement Disorders: An Abbreviated Overview
Thyagarajan, D. E. (2001) · Stereotactic and Functional Neurosurgery · doi:10.1159/000064597 · Cited by 1
Early conformational changes control spontaneous polyQ-mediated huntingtin polymerization
Wagner, A. S. (2012) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-8800 · Cited by 1
Silencing Huntington’s Disease Gene with RNAi
Zhang, Y., & Friedlander, R. M. (2010) · RNA technologies · doi:10.1007/978-3-642-12168-5_6 · Cited by 1
Calcium Channel Dysfunction in Huntington’s Disease
Cherry, S. (2009) · doi:10.21007/etd.cghs.2009.0051 · Cited by 1
Papel de GSK-3 y Tau en la enfermedad de Huntington
Nogales, M. F. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Spinocerebellar Ataxia and Other Disorders of Trinucleotide Repeats
Zoghbi, H. Y. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-726-0_100 · Cited by 1
Knock-in and Knock-out Models of Huntington Disease
Dietrich, P., & Dragatsis, I. (2005) · Elsevier eBooks · doi:10.1016/b978-012088382-0/50028-1 · Cited by 1
Effects of Parkin and mutant Huntingtin on the NF-kB signaling pathway
Patra, M. (2015) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.19974 · Cited by 1
Trinucleotide Repeats in Transgenic Mice: New Insights
Longo, F. M., & Massa, S. M. (1997) · The Neuroscientist · doi:10.1177/107385849700300507 · Cited by 1
DNA Repair Deficiency in Huntington's Disease Fibroblasts and Induced Pluripotent Stem Cells
Mollica, P. A. (2015) · ODU Digital Commons (Old Dominion University) · doi:10.25777/r105-c396 · Cited by 1
Population genetics and allele-specific silencing of the Huntington disease mutation
Kay, C. (2017) · cIRcle (University of British Columbia) · doi:10.14288/1.0347579 · Cited by 1
Pathogenetische Bedeutung von intrazellulären Huntingtinaggregaten beim Morbus Huntington
Kuemmerle, S. (2003) · mediaTUM (Technical University of Munich) · Cited by 1
Role of autophagy in GM1-mediated neuroprotection in Huntington's Disease
Schmelz, S. (2016) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3sj1b59m · Cited by 1
Papel del factor de transcripción ATF5 en la Enfermedad de Huntington
Hernández, I. H. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Naia, L. (2017) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Kassem, R. (2023) · theses.fr (ABES) · doi:10.70675/ed54144dz7e3ez4ad8zbd58zcd2ad32ccc9e · Cited by 1
Willam, M. (2018) · Gutenberg Open Science · doi:10.25358/openscience-1163 · Cited by 1
Molekulargenetische Untersuchungen zum genetischen Hintergrund bei Morbus Huntington (MH)
Valentin, S. (2005) · Dokumentenrepositorium der RUB (Ruhr University Bochum) · Cited by 1
Barazorda-Ccahuana, H. L. (2006) · renati · Cited by 1
Findlay Black, H. (2025) · cIRcle (University of British Columbia) · doi:10.14288/1.0449937 · Cited by 1
Feyeux, M. (2011) · theses.fr (ABES) · doi:10.70675/d3786477zc560z42e3za489z601932156212 · Cited by 1
Retinal ciliopathies in Huntington's and SCA7 disorders
Karam, A. (2013) · theses.fr (ABES) · doi:10.70675/05655d6fz83e2z48dbz908cz299f8b8b30e6 · Cited by 1
de Longprez, L. (2018) · theses.fr (ABES) · doi:10.70675/9c720f01z8077z49d5z9df8z8e7cc0c69a1a · Cited by 1
Lotz, C. (2019) · theses.fr (ABES) · doi:10.70675/35213e27zda27z484az886azd1ed4013e75a · Cited by 1
The role of the serum response factor in the pathogenesis of Huntington's disease
Awada, A. (2021) · theses.fr (ABES) · doi:10.70675/fabef4b5z9d78z440bz99f2z9be7d0814a03 · Cited by 1
Kordower (1999) · doi:10.1002/1531-8249(199909)46:3
Expression and functional analysis of the SCA7 disease protein ataxin-7.
Ström, A. (2004) · DiVA at Umeå University (Umeå University)
Characterization of mechanisms underlying neuronal survival and plasticity in Huntington's disease
Anglada‐Huguet, M. (2013) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Molekulare Grundlagen neurologischer Trinukleotidblockexpansionssyndrome
Epplen, J. T., & Haupt, A. (2000) · Springer eBooks · doi:10.1007/978-3-642-57043-8_18
Mechanics of Heart Tube Formation in the Early Chick Embryo
Varner, V. D. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7x0651d
Coufal, M. (2006) · DSpace@MIT (Massachusetts Institute of Technology)
Clearance of intracellular aggregation-prone protein fragments
Gillis, J. M. E. P. (2009) · UvA-DARE (University of Amsterdam)
Welsch, K. D. (2010) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-14110
Novel methods and therapeutic approaches of diagnosis and treatment of Huntington's disease
Weiss, A. (2008) · edoc (University of Basel) · doi:10.5451/unibas-004648909
Investigation of the role of collapsin response mediator 4 in Huntington's disease
Nicoletti, C. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-10651
Trinukleotid-Repeat-Erkrankungen
Klockgether, T., & Weller, M. (1999) · Springer eBooks · doi:10.1007/978-3-662-07096-3_3
Pallos, J. (2012) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.1071
Giralt, A. (2010) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
The role of Huntingtin in fast axonal transport
Weiss, K. R. (2012) · DSpace@MIT (Massachusetts Institute of Technology)
Application of a Drosophila model to study Huntington's disease pathogenesis in vivo
Bodai, L. (2004) · SZTE Repository of Dissertations (University of Szeged)
Estudio in vivo del sistema ubiquitina proteasoma en modelos animales de la enfermedad de Huntington
Ortega, Z. (2010) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
CDNF in an experimental model of Parkinson's disease: studies on gene therapy and protein infusion
Bäck, S. (2014) · Helda - University of Helsinki Institutional Repository
Kremer, H., & Knoers, N. V. A. M. (1996) · PubMed
Gozzelino, R. (2007) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Baldo, B. (2011) · edoc (University of Basel) · doi:10.5451/unibas-005705769
Genetic and Functional Analysis of Androgen Receptor Gene Mutations
Brüggenwirth, H. T. (1998) · EUR Research Repository (Erasmus University Rotterdam)
Polyglutamine Aggregates as a Model for Protein‐misfolding Diseases
Kim, S., Morley, J. F., Ben‐Zvi, A., & Morimoto, R. I. (2005) · Wiley eBooks · doi:10.1002/9783527619498.ch69
Thomas, P. S., & Spada, A. R. L. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.055
Lee, B. M. (2011) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-pvz6jkkax
Characterization of in vitro and in vivo huntingtin proteolysis in Huntington's disease
Tebbenkamp, A. T. N. (2010) · University of Florida Digital Collections (University of Florida)
Estudio de las vías de supervivencia y muerte neuronal en modelos de la enfermedad de Huntington
Rubia, P. P. (2010) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
β-cell dysfunction in Huntington's disease
Bacos, K. (2009) · Lund University Publications (Lund University)
Burg, M., & Jorien, M. (2008) · Lund University Publications (Lund University)
Role of the MID1/α4 protein complex in Huntington’s disease
Jastrzebska, E. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-6893
Shu, H. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511581410.003
Glutamincluster und Neurodegeneration
Maelicke, A. (1996) · Nachrichten aus Chemie Technik und Laboratorium · doi:10.1002/nadc.19960440116
Cantle, J. P., Lu, X., Gu, X., & Yang, X. W. (2012) · Frontiers in Biology · doi:10.1007/s11515-012-1246-7
B10 The role of n-terminal phosphorylation in huntingtin's oligomerisation, aggregation and toxicity
Herrera, F., dos Santos, J. B., & Outeiro, T. F. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303524.26
Polyglutamine monomer structure and its implications for molecular self-assembly
VanSchouwen, B. (2009) · Brock University Digital Repository (Brock University)
Bioenergetic Defects and Oxidative Damage in Transgenic Mouse Models of Neurodegenerative Disorders
Browne, S. E. (2003) · Defense Technical Information Center (DTIC) · doi:10.21236/ada419306
Metadata
- Authors
- Duyao, M. P., Auerbach, A. B., Ryan, A., Persichetti, F., Barnes, G. T., McNeil, S. M., Ge, P., Vonsattel, J.-P., Gusella, J. F., Joyner, A. L., & MacDonald, M. E.
- Affiliations
- Massachusetts General Hospital (US)
- Mount Sinai Hospital (CA)
- Corresponding author
- MacDonald, Marcy E.
- Venue
- Science
- Published
- 1995-07-21
- Volume
- 269
- Issue
- 5222
- Pages
- 407-410
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2002644780
- Cited by
- 723
- References
- 29
- Citations by year
- 2026: 13 · 2025: 18 · 2024: 15 · 2023: 16 · 2022: 18 · 2021: 26 · 2020: 20 · 2019: 22 · 2018: 20 · 2017: 26 · 2016: 20 · 2015: 21 · 2014: 33 · 2013: 22 · 2012: 32
- FWCI
- 12.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS 16367, NS32765, R01NS032765)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- Huntington's disease, huntingtin, gene targeting, embryonic lethality, gastrulation, loss of function, gain-of-function, CAG repeat expansion, mouse model, neurodegeneration
- MeSH terms
- Huntingtin Protein, Animals, Base Sequence, Cell Line, Ectoderm, Female, Embryonic and Fetal Development, Genotype, Heterozygote, Homozygote, Humans, Huntington Disease, Male, Mesoderm, Mice, Inbred C57BL, Molecular Sequence Data, Nerve Tissue Proteins, Nuclear Proteins, Phenotype, Stem Cells, Gene Targeting, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.